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By Silvia Marchesan1, Laura Ballerini,2 
Maurizio Prato1, 3, 4
D
espite recent advances in supportive 
care for spinal cord injury (SCI), there 
is a great need for treatments that can 
improve the neurological outcome 
(1). After SCI, there is essentially no 
regrowth of axons beyond the point 
of the lesion, leaving intact, although non-
functional, circuits below the site of injury. 
We discuss the potential for functional re-
covery from SCI by using nanomaterials to 
restore these dysfunctional circuits through 
a combination of artificial connections and 
devices to help stimulate motor and sensory 
recovery. 
Because SCI interrupts axons and alters 
myelination, which impairs sensory and 
motor pathways, recovery of lesion in spi-
nal tissue involves regeneration of the long 
neuronal tracts mediating such functions. 
To date, key neuroregenerative strategies in-
clude cell-based therapies as well as implant-
able synthetic scaffolds, to promote stem cell 
differentiation into nerve tissue to bridge 
across the lesion site. Alternatively, implant-
able neuroprostheses can also be engineered 
to contain electrodes for recording and 
stimulation; however, the state-of-the-art is 
far from reaching optimal stability of the de-
vice at the synthetic-biological interface (2). 
These combined approaches represent one 
of the more promising avenues, although 
fine control over implant and long-term cell 
fate remain to be demonstrated. Typically, 
implants are composed of stiff and static 
materials defined at best to the micrometer 
scale, including silicone and stainless-steel 
elements, and platinum-iridium electrodes 
that are ultimately rejected by the human 
organism (3).
Nanomaterials have the potential to cre-
ate more active scaffolds that enable in-
timate tissue interactions to form truly 
biohybridized systems. In many applica-
tions, nanostructures hold the potential to 
increase cell viability and adhesion to pre-
manufactured three-dimensional (3D) scaf-
folds. Engineered nanomaterials coupled to 
microtechnology may also act as electrodes 
to stimulate neural tissue and record activ-
ity (4). Ideally, the scaffold should promote 
natural tissue regeneration and axon remod-
eling to either reconnect neurons, or at least 
electrically bridge between them where the 
contact was lost. Once functional connec-
tion is reestablished, the scaffold should be 
resorbed to leave only natural tissue in place. 
If permanent integration is needed, the elec-
trical bridge should be free from risks of 
long-term side effects, something that is not 
currently achieved with traditional implants. 
Stiffness, mechanical compliance with the 
neural tissue, and size are the guiding rules 
to developing 3D implants able to reach 
unprecedented biological integration. An 
implantable bridge must match the shape 
and elasticity of human tissue for long-term, 
high-quality performance. Neural tissue is 
soft; its shear modulus is between 0.2 and 
10 kPa, depending on age and anatomic re-
gion, similar to the softest gelatins. Recently, 
neural implants were prepared with elastic 
materials designed to meet the mechanical 
properties of spinal and brain tissues. Sub-
dural implantation of an electronic device 
into the dura mater—that is, the outermost 
of the three membranes that envelop the 
brain and spinal cord and is located immedi-
ately under the bone—provides an intimate 
interface for the integration of electronics 
and microfluidics to stimulate neurons (3). 
For additional technological advancements 
to reach patients, optimal electrode densities 
and embedded electronics for real-time read-
ing and writing into the nervous system will 
be needed.
Supramolecular hydrogels have the visco-
elastic and dynamic character of neural tis-
sue but typically lack the high conductivity 
required for interfaces with electrically ac-
tive tissues, as well as the high resilience to 
sustain the mechanical stress that the spinal 
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cord faces. Hydrogel integration with nano-
materials such as carbon nanotubes (CNTs) 
could impart the needed properties, and 
CNT-based scaffolds revealed a remarkable 
ability to guide the connectivity of neural 
networks. However, the chemical function-
alization needed to lessen the aggregation-
induced cytotoxicity of CNTs can reduce 
their electrical conductivity, and thus must 
be designed ad hoc (5). 
Chemical vapor deposition (CVD) can cre-
ate a nanoporous network of unfunctional-
ized CNTs that is well organized through 
space in a scaffold and avoids the issue of 
CNT aggregation when used in solution. The 
successful integration between networks 
of neurons and CNTs can be maximized in 
three dimensions, as shown by the growth 
of a neural web on a CVD-derived mesh of 
pure CNTs that supports the reconnection 
of segregated spinal cord segments. Its con-
ductivity increases linearly from 3.5 to 25 
S m–1 when compressed and more contacts 
are made. Such CNT scaffolds, besides in-
ducing a low inflammatory response when 
implanted, possess an ideal morphology for 
the biointegration with regrowing neuronal 
fiber (see the figure) (6). An elongated mor-
phology indeed appears to be key for effi-
cient communication with neurons toward 
their integration into hybrid systems. 
Graphene has been introduced in flex-
ible and stretchable electronics for wearable 
devices and implants in both ex vivo and in 
vivo contexts, proving superior performance, 
in terms of sensitivity and resolution, over 
conventional methods (7). Properties simi-
lar to those of the CNT networks can be ex-
tended to graphene that is electrospun into 
nanofibers, which were implanted to provide 
axonal guidance through their elongated 
morphology, and even attract migrating neu-
roblasts from their brain niche (8). This re-
cruitment provides a needed capability; the 
spinal cord is a source of stem cells, but at 
present there is no way to direct them to the 
lesion site.
Injectable nanostructured bioelectronics 
are needed to develop high-density neural-
electronic interfaces, with semiconductor 
nanomaterials such as silicon nanowires, 
CNTs, and graphene showing great promise 
(4), provided that they are outer-functional-
ized with softer components to match neural 
tissue elasticity. For instance, addition of a 
biomimetic peptide allows biointegration 
without compromising cell activity (9). Self-
assembling peptides and peptide amphiphi-
les can present minimalist bioactive motifs 
with high density to promote neural stem 
cell differentiation for SCI (10). They self-
organize into supramolecular hydrogels ca-
pable of dynamic behavior (e.g., self-healing) 
with the additional benefit of high degrees 
of internal order, which are ideal for the bio-
mimicry of hierarchical architectures that 
occur in tissues (11). 
Combined approaches are an effective way 
to maximize recovery. Experiments in small 
mammals showed that pharmacological in-
tervention synergizes with physical training 
to induce treadmill locomotion, given that 
the body weight is supported (12). In addi-
tion, the residual regenerative capacity of 
intraspinal circuits to bypass lesions can be 
experimentally improved via activity-based 
plasticity processes, motivating active par-
ticipation of the animal—for instance, by 
encouraging movement to reach a food re-
ward, versus mindless treadmill locomotion. 
A study on paralyzed primates established a 
brain-spine interface that restored weight-
bearing locomotion by means of a wireless 
system consisting of microelectrode arrays 
implanted in the brain cortex and a stimu-
lating implant in the spinal cord (13). In 
paraplegic patients, clinical studies, where 
long-term training by brain-machine inter-
faces was combined with virtual reality and 
robotic actuators, reported  the occurrence 
of partial neurological recovery.  This recov-
ery was associated to the resurgence of lost 
motor imagery in the cortex (14).
Implantable structures have the potential 
to artificially bridge neurons or recruit neu-
rons to restore connectivity. Injectable nano-
electronics that cooperate with the patient’s 
brain to restore spinal function may gener-
ate hybrid structures able to cross the bar-
riers between artificial and natural systems. 
Many challenges remain in learning how to 
restore neuronal systems through designed 
nanostructures, but the very open design 
space of these approaches will help enable 
successful outcomes. j
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B
lack eumelanin pigments play a key 
role in determining skin and hair 
color in humans and other animals. 
In the body, they are produced by 
enzymatic conversion of tyrosine to 
dopaquinone, followed by oxidative 
polymerization (1). Synthetic eumelanin-
type biopolymers—such as mussel-inspired 
polydopamine (2)—have optical, electronic, 
and free-radical properties that make them 
attractive for materials and biomedicine ap-
plications. However, it remains difficult to 
control and tune the properties of eumela-
nin-type biopolymers. On page xxx of this 
issue, Lampel et al.  (3) show that tyrosine-
containing tripeptides can serve as tunable 
precursors for polymeric eumelanin-like 
pigments, with properties that depend on 
the peptide sequence and the degree of su-
pramolecular order that it imparts. 
Development of eumelanin-based tech-
nologies requires a deep understanding of 
the mechanisms that govern the formation 
of the disordered oligomer assemblies that 
make up the supramolecular architecture 
of eumelanins. Such understanding may 
lead to a rational strategy for controlling 
and tuning aggregation-dependent optical, 
electronic, free-radical, and adhesion prop-
erties. Moreover, there is a need for ver-
satile and efficient approaches to process 
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